...
首页> 外文期刊>Acute and critical care. >The Efficacy of Early Goal-directed Therapy in Septic Shock Patients in the Emergency Department: Severe Sepsis Campaign
【24h】

The Efficacy of Early Goal-directed Therapy in Septic Shock Patients in the Emergency Department: Severe Sepsis Campaign

机译:急诊科中败血症性休克患者早期目标导向疗法的疗效:严重脓毒症运动

获取原文

摘要

BACKGROUND: Early goal-directed therapy (EGDT) has been used for patients with severe sepsis and septic shock in the emergency department (ED). In 2003, international management guidelines for severe sepsis and septic shock were developed under the auspices of the Surviving Sepsis Campaign (SSC); however, EGDT based on the SSC was not fully evaluated in the ED. The purpose of this study was to evaluate the efficacy of EGDT based on the SSC in the ED in Korea. METHODS: We randomly assigned patients who arrived at our ED in septic shock to receive EGDT before admission to the intensive care unit between May 2007 and July 2007, and we retrospectively assigned patients in septic shock to receive standard therapy between May 2006 and July 2006. The in-hospital mortality for 24 hours and 28 days, the MODS, SAPS II, and APACHE II scores were obtained and compared between the study groups. RESULTS: Of the 60 enrolled patients, 30 were assigned to EGDT and 30 were assigned to standard therapy. There was no significant difference between the groups with respect to the baseline characteristics. In-hospital mortality at 28 days was 13% in the group assigned to EGDT as compared to 40% in the group assigned to standard therapy (p = 0.020) and in-hospital mortality at 24 hours was 0% and 13%, respectively (p = 0.038). CONCLUSIONS: EGDT provides significant benefits with respect to outcome in patients in septic shock.
机译:背景:早期的目标导向疗法(EGDT)已用于急诊室(ED)患有严重败血症和败血性休克的患者。 2003年,在幸存脓毒症运动(SSC)的主持下,制定了关于严重脓毒症和败血性休克的国际管理指南;但是,ED中并未完全评估基于SSC的EGDT。这项研究的目的是评估韩国急诊科中基于SSC的EGDT的疗效。方法:我们随机分配在2007年5月至2007年7月期间进入重症监护病房的感染性休克急诊就诊的患者接受EGDT,并回顾性分配在2006年5月至2006年7月之间接受标准疗法的脓毒性休克患者。获得了24小时和28天的院内死亡率,MODS,SAPS II和APACHE II评分,并在研究组之间进行了比较。结果:在这60名患者中,有30名被分配到EGDT中,有30名被分配到标准疗法中。两组之间的基线特征没有显着差异。 EGDT治疗组在28天的住院死亡率为13%,而标准疗法治疗组为40%(p = 0.020),24小时住院死亡率分别为0%和13%( p = 0.038)。结论:败血性休克患者的EGDT可显着改善预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号